Farsad Eskandary

9PUBLICATIONS
49CO-AUTHORS
HaematologyCellular nervous systemAutoimmunityApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Medical biotechnology diagnostics (incl. biosensors)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Nov 16, 2024
The factor XI/XIa antibody abelacimab combined with enoxaparin inhibits filter clotting in hemodialysis circuits ex vivo.

Juergen Grafeneder, Gesche Langer, Christian Schoergenhofer

|Aug 27, 2021
Diagnostic value of donor-derived cell-free DNA to predict antibody-mediated rejection in donor-specific antibody-positive renal allograft recipients.

Katharina A Mayer, Konstantin Doberer, Amanda Tillgren

|Jun 21, 2021
Anti-interleukin-6 antibody clazakizumab in late antibody-mediated kidney transplant rejection: effect on cytochrome P450 drug metabolism.

Jakob Mühlbacher, Christian Schörgenhofer, Konstantin Doberer

|May 13, 2021
Renal allograft DARCness in subclinical acute and chronic active ABMR.

Johannes Kläger, Farsad Eskandary, Georg A Böhmig

|Feb 09, 2020
Torque teno virus for risk stratification of graft rejection and infection in kidney transplant recipients-A prospective observational trial.

Konstantin Doberer, Martin Schiemann, Robert Strassl

Pageof 2